Efficacy of satralizumab as monotherapy in pre-specified subgroups of SAkuraStar, a double-blind placebo-controlled phase 3 clinical study in patients with neuromyelitis optica spectrum disorder (NMOSD)

Subjects

Subjects :

Pediatrics
medicine.medical_specialty
Neuromyelitis optica
business.industry
Placebo
medicine.disease
Double blind
Clinical study
Neurology
medicine
In patient
Spectrum disorder
Neurology (clinical)
business

Details

ISSN :

0022510X

Volume :

405

Database :

OpenAIRE

Journal :

Journal of the Neurological Sciences

Accession number :

edsair.doi...........3a97fffc20075cf70fdcc85b9e1397cc

Full Text :

https://doi.org/10.1016/j.jns.2019.10.1109